Eton Pharmaceuticals Inc has a share price target of US$ 28, revenue growth forecast of 88.6%, and profit growth estimate of 381.4% for FY25, based on top 3 analyst calls.
Upgrade Your Plan
You need to upgrade your subscription plan to access this feature